Vergent Bioscience, Inc.
New Filing
CIK: 0001741495·Biotechnology·DELAWARE·Filed: Oct 20, 2025
Total Offering
$31,957,273
Amount Sold
$18,673,277
Investors
20
First Sale
Oct 7, 2025
Offering Details
- Type
- Equity, Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| John T. Santini, Jr. | Related Person |
| Douglas Kohrs | Related Person |
| Raymond Wong | Related Person |
| Bobby Helmedag | Related Person |
| Anita Watkins | Related Person |
| Jeffrey Yurecko | Related Person |
Company
SEC Filing
0001741495-25-000004
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free